nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextromethorphan—PGRMC1—prostate cancer	0.229	0.731	CbGaD
Dextromethorphan—Dezocine—Estrone—prostate cancer	0.0548	0.173	CrCrCtD
Dextromethorphan—Levorphanol—Estrone—prostate cancer	0.0425	0.134	CrCrCtD
Dextromethorphan—Dezocine—Estradiol—prostate cancer	0.0415	0.131	CrCrCtD
Dextromethorphan—Mestranol—Estramustine—prostate cancer	0.0396	0.125	CrCrCtD
Dextromethorphan—Levorphanol—Estradiol—prostate cancer	0.0322	0.102	CrCrCtD
Dextromethorphan—Mestranol—Estrone—prostate cancer	0.0315	0.0993	CrCrCtD
Dextromethorphan—CYP3A5—prostate cancer	0.0302	0.0962	CbGaD
Dextromethorphan—Mestranol—Conjugated Estrogens—prostate cancer	0.0277	0.0874	CrCrCtD
Dextromethorphan—Mestranol—Estradiol—prostate cancer	0.0238	0.0753	CrCrCtD
Dextromethorphan—Mestranol—Ethinyl Estradiol—prostate cancer	0.0233	0.0735	CrCrCtD
Dextromethorphan—CYP2E1—prostate cancer	0.0207	0.0661	CbGaD
Dextromethorphan—CYP2C19—prostate cancer	0.0205	0.0655	CbGaD
Dextromethorphan—CYP3A4—prostate cancer	0.0131	0.0416	CbGaD
Dextromethorphan—CYP2C8—Nilutamide—prostate cancer	0.01	0.0405	CbGbCtD
Dextromethorphan—CYP3A5—Flutamide—prostate cancer	0.00865	0.0349	CbGbCtD
Dextromethorphan—CYP2C19—Nilutamide—prostate cancer	0.00842	0.034	CbGbCtD
Dextromethorphan—CYP2C19—Bicalutamide—prostate cancer	0.00842	0.034	CbGbCtD
Dextromethorphan—CYP2C8—Abiraterone—prostate cancer	0.00832	0.0335	CbGbCtD
Dextromethorphan—CYP2E1—Estrone—prostate cancer	0.00805	0.0325	CbGbCtD
Dextromethorphan—CYP2B6—Estrone—prostate cancer	0.00794	0.032	CbGbCtD
Dextromethorphan—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00775	0.0313	CbGbCtD
Dextromethorphan—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00708	0.0285	CbGbCtD
Dextromethorphan—CYP2C9—Nilutamide—prostate cancer	0.007	0.0282	CbGbCtD
Dextromethorphan—CYP2C9—Bicalutamide—prostate cancer	0.007	0.0282	CbGbCtD
Dextromethorphan—CYP2C19—Flutamide—prostate cancer	0.00698	0.0281	CbGbCtD
Dextromethorphan—CYP2D6—Bicalutamide—prostate cancer	0.0064	0.0258	CbGbCtD
Dextromethorphan—CYP3A5—Cabazitaxel—prostate cancer	0.0064	0.0258	CbGbCtD
Dextromethorphan—ABCB1—Estramustine—prostate cancer	0.00632	0.0255	CbGbCtD
Dextromethorphan—CYP3A5—Estrone—prostate cancer	0.00626	0.0252	CbGbCtD
Dextromethorphan—CYP2C8—Cabazitaxel—prostate cancer	0.00616	0.0248	CbGbCtD
Dextromethorphan—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00536	0.0216	CbGbCtD
Dextromethorphan—CYP2D6—Abiraterone—prostate cancer	0.00531	0.0214	CbGbCtD
Dextromethorphan—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00479	0.0193	CbGbCtD
Dextromethorphan—CYP3A7—Estradiol—prostate cancer	0.00479	0.0193	CbGbCtD
Dextromethorphan—CYP2E1—Mitoxantrone—prostate cancer	0.00479	0.0193	CbGbCtD
Dextromethorphan—CYP2C9—Estrone—prostate cancer	0.0042	0.0169	CbGbCtD
Dextromethorphan—ABCB1—Cabazitaxel—prostate cancer	0.00417	0.0168	CbGbCtD
Dextromethorphan—CYP3A4—Bicalutamide—prostate cancer	0.00407	0.0164	CbGbCtD
Dextromethorphan—ABCB1—Estrone—prostate cancer	0.00407	0.0164	CbGbCtD
Dextromethorphan—CYP3A4—Estramustine—prostate cancer	0.00379	0.0153	CbGbCtD
Dextromethorphan—ABCB1—Ethinyl Estradiol—prostate cancer	0.00363	0.0146	CbGbCtD
Dextromethorphan—CYP3A5—Estradiol—prostate cancer	0.00359	0.0145	CbGbCtD
Dextromethorphan—CYP2C8—Estradiol—prostate cancer	0.00346	0.0139	CbGbCtD
Dextromethorphan—CYP3A4—Flutamide—prostate cancer	0.00337	0.0136	CbGbCtD
Dextromethorphan—CYP3A4—Abiraterone—prostate cancer	0.00337	0.0136	CbGbCtD
Dextromethorphan—CYP2C9—Capecitabine—prostate cancer	0.00318	0.0128	CbGbCtD
Dextromethorphan—CYP2E1—Etoposide—prostate cancer	0.00302	0.0122	CbGbCtD
Dextromethorphan—CYP2C19—Estradiol—prostate cancer	0.0029	0.0117	CbGbCtD
Dextromethorphan—CYP3A7—Docetaxel—prostate cancer	0.00286	0.0115	CbGbCtD
Dextromethorphan—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00286	0.0115	CbGbCtD
Dextromethorphan—ABCB1—Conjugated Estrogens—prostate cancer	0.00266	0.0107	CbGbCtD
Dextromethorphan—CYP3A4—Cabazitaxel—prostate cancer	0.0025	0.0101	CbGbCtD
Dextromethorphan—CYP2C19—Prednisone—prostate cancer	0.00249	0.01	CbGbCtD
Dextromethorphan—CYP3A4—Estrone—prostate cancer	0.00244	0.00984	CbGbCtD
Dextromethorphan—ABCB1—Mitoxantrone—prostate cancer	0.00242	0.00976	CbGbCtD
Dextromethorphan—CYP2C9—Estradiol—prostate cancer	0.00241	0.00972	CbGbCtD
Dextromethorphan—CYP3A5—Etoposide—prostate cancer	0.00235	0.00946	CbGbCtD
Dextromethorphan—ABCB1—Estradiol—prostate cancer	0.00234	0.00943	CbGbCtD
Dextromethorphan—CYP2C8—Etoposide—prostate cancer	0.00226	0.0091	CbGbCtD
Dextromethorphan—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00217	0.00877	CbGbCtD
Dextromethorphan—CYP3A5—Docetaxel—prostate cancer	0.00215	0.00866	CbGbCtD
Dextromethorphan—CYP2B6—Doxorubicin—prostate cancer	0.00203	0.00819	CbGbCtD
Dextromethorphan—ABCB1—Prednisone—prostate cancer	0.00201	0.00811	CbGbCtD
Dextromethorphan—CYP3A4—Conjugated Estrogens—prostate cancer	0.0016	0.00644	CbGbCtD
Dextromethorphan—ABCB1—Etoposide—prostate cancer	0.00153	0.00616	CbGbCtD
Dextromethorphan—CYP3A4—Mitoxantrone—prostate cancer	0.00145	0.00585	CbGbCtD
Dextromethorphan—CYP3A4—Estradiol—prostate cancer	0.0014	0.00565	CbGbCtD
Dextromethorphan—ABCB1—Docetaxel—prostate cancer	0.0014	0.00563	CbGbCtD
Dextromethorphan—CYP3A4—Prednisone—prostate cancer	0.00121	0.00486	CbGbCtD
Dextromethorphan—PGRMC1—prostate gland—prostate cancer	0.00118	0.0544	CbGeAlD
Dextromethorphan—ABCB1—Doxorubicin—prostate cancer	0.00104	0.0042	CbGbCtD
Dextromethorphan—PGRMC1—seminal vesicle—prostate cancer	0.001	0.046	CbGeAlD
Dextromethorphan—CYP2D6—Doxorubicin—prostate cancer	0.000981	0.00396	CbGbCtD
Dextromethorphan—CYP2C19—urine—prostate cancer	0.000954	0.0438	CbGeAlD
Dextromethorphan—CYP3A4—Etoposide—prostate cancer	0.000915	0.00369	CbGbCtD
Dextromethorphan—CHRNB2—prostate gland—prostate cancer	0.000841	0.0386	CbGeAlD
Dextromethorphan—CYP3A4—Docetaxel—prostate cancer	0.000837	0.00338	CbGbCtD
Dextromethorphan—CHRNA3—prostate gland—prostate cancer	0.000816	0.0375	CbGeAlD
Dextromethorphan—PGRMC1—renal system—prostate cancer	0.000806	0.0371	CbGeAlD
Dextromethorphan—PGRMC1—urethra—prostate cancer	0.000792	0.0364	CbGeAlD
Dextromethorphan—CHRNA2—prostate gland—prostate cancer	0.000758	0.0348	CbGeAlD
Dextromethorphan—CYP2C9—urine—prostate cancer	0.000739	0.034	CbGeAlD
Dextromethorphan—CYP2E1—urine—prostate cancer	0.000701	0.0322	CbGeAlD
Dextromethorphan—OPRK1—prostate gland—prostate cancer	0.000698	0.0321	CbGeAlD
Dextromethorphan—CYP3A4—Doxorubicin—prostate cancer	0.000624	0.00252	CbGbCtD
Dextromethorphan—PGRMC1—bone marrow—prostate cancer	0.00061	0.028	CbGeAlD
Dextromethorphan—CHRNB4—testis—prostate cancer	0.000586	0.0269	CbGeAlD
Dextromethorphan—CYP3A4—urine—prostate cancer	0.000564	0.0259	CbGeAlD
Dextromethorphan—CHRNB2—urethra—prostate cancer	0.000563	0.0259	CbGeAlD
Dextromethorphan—CYP2D6—urine—prostate cancer	0.000555	0.0255	CbGeAlD
Dextromethorphan—PGRMC1—testis—prostate cancer	0.000521	0.0239	CbGeAlD
Dextromethorphan—OPRD1—renal system—prostate cancer	0.000497	0.0228	CbGeAlD
Dextromethorphan—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000467	1	CbGdCrCtD
Dextromethorphan—GRIN3A—testis—prostate cancer	0.000455	0.0209	CbGeAlD
Dextromethorphan—CHRNB2—bone marrow—prostate cancer	0.000433	0.0199	CbGeAlD
Dextromethorphan—SIGMAR1—prostate gland—prostate cancer	0.00041	0.0189	CbGeAlD
Dextromethorphan—PGRMC1—lymph node—prostate cancer	0.000378	0.0174	CbGeAlD
Dextromethorphan—CHRNB2—testis—prostate cancer	0.00037	0.017	CbGeAlD
Dextromethorphan—CHRNA7—renal system—prostate cancer	0.000363	0.0167	CbGeAlD
Dextromethorphan—CHRNA3—testis—prostate cancer	0.000359	0.0165	CbGeAlD
Dextromethorphan—SIGMAR1—seminal vesicle—prostate cancer	0.000347	0.016	CbGeAlD
Dextromethorphan—CHRFAM7A—testis—prostate cancer	0.000291	0.0134	CbGeAlD
Dextromethorphan—SIGMAR1—urethra—prostate cancer	0.000275	0.0126	CbGeAlD
Dextromethorphan—CYP3A5—prostate gland—prostate cancer	0.00027	0.0124	CbGeAlD
Dextromethorphan—CHRNB2—lymph node—prostate cancer	0.000269	0.0123	CbGeAlD
Dextromethorphan—CHRNA3—lymph node—prostate cancer	0.00026	0.012	CbGeAlD
Dextromethorphan—CYP2E1—prostate gland—prostate cancer	0.000252	0.0116	CbGeAlD
Dextromethorphan—CHRNA7—testis—prostate cancer	0.000235	0.0108	CbGeAlD
Dextromethorphan—OPRM1—testis—prostate cancer	0.000219	0.0101	CbGeAlD
Dextromethorphan—CYP2E1—seminal vesicle—prostate cancer	0.000213	0.00978	CbGeAlD
Dextromethorphan—SIGMAR1—bone marrow—prostate cancer	0.000211	0.00972	CbGeAlD
Dextromethorphan—CYP2C8—renal system—prostate cancer	0.000204	0.00936	CbGeAlD
Dextromethorphan—Mestranol—ESR1—prostate cancer	0.000203	0.21	CrCbGaD
Dextromethorphan—Codeine—SLC22A1—prostate cancer	0.000189	0.195	CrCbGaD
Dextromethorphan—Abdominal pain—Degarelix—prostate cancer	0.000185	0.00435	CcSEcCtD
Dextromethorphan—CYP3A5—renal system—prostate cancer	0.000184	0.00845	CbGeAlD
Dextromethorphan—CYP2B6—renal system—prostate cancer	0.000183	0.0084	CbGeAlD
Dextromethorphan—Vomiting—Abiraterone—prostate cancer	0.000182	0.00428	CcSEcCtD
Dextromethorphan—Feeling abnormal—Cabazitaxel—prostate cancer	0.000181	0.00427	CcSEcCtD
Dextromethorphan—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000181	0.00426	CcSEcCtD
Dextromethorphan—SIGMAR1—testis—prostate cancer	0.000181	0.00831	CbGeAlD
Dextromethorphan—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.00018	0.00423	CcSEcCtD
Dextromethorphan—Vomiting—Estrone—prostate cancer	0.000179	0.00421	CcSEcCtD
Dextromethorphan—Diarrhoea—Nilutamide—prostate cancer	0.000179	0.00421	CcSEcCtD
Dextromethorphan—Diarrhoea—Flutamide—prostate cancer	0.000178	0.00419	CcSEcCtD
Dextromethorphan—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000176	0.00415	CcSEcCtD
Dextromethorphan—Abdominal discomfort—Estradiol—prostate cancer	0.000176	0.00413	CcSEcCtD
Dextromethorphan—Nausea—Estramustine—prostate cancer	0.000175	0.00412	CcSEcCtD
Dextromethorphan—Abdominal pain—Cabazitaxel—prostate cancer	0.000174	0.00409	CcSEcCtD
Dextromethorphan—Dizziness—Nilutamide—prostate cancer	0.000173	0.00407	CcSEcCtD
Dextromethorphan—Dizziness—Flutamide—prostate cancer	0.000172	0.00405	CcSEcCtD
Dextromethorphan—Hypersensitivity—Degarelix—prostate cancer	0.000172	0.00405	CcSEcCtD
Dextromethorphan—CYP2E1—renal system—prostate cancer	0.000171	0.00788	CbGeAlD
Dextromethorphan—CYP2E1—urethra—prostate cancer	0.000168	0.00774	CbGeAlD
Dextromethorphan—Somnolence—Bicalutamide—prostate cancer	0.000168	0.00395	CcSEcCtD
Dextromethorphan—Asthenia—Degarelix—prostate cancer	0.000168	0.00394	CcSEcCtD
Dextromethorphan—Nausea—Estrone—prostate cancer	0.000167	0.00394	CcSEcCtD
Dextromethorphan—Immune system disorder—Goserelin—prostate cancer	0.000167	0.00393	CcSEcCtD
Dextromethorphan—Vomiting—Nilutamide—prostate cancer	0.000166	0.00391	CcSEcCtD
Dextromethorphan—Dyspepsia—Bicalutamide—prostate cancer	0.000166	0.00391	CcSEcCtD
Dextromethorphan—Vomiting—Flutamide—prostate cancer	0.000166	0.0039	CcSEcCtD
Dextromethorphan—Immune system disorder—Conjugated Estrogens—prostate cancer	0.000165	0.00389	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000163	0.00384	CcSEcCtD
Dextromethorphan—Fatigue—Bicalutamide—prostate cancer	0.000163	0.00383	CcSEcCtD
Dextromethorphan—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000163	0.00382	CcSEcCtD
Dextromethorphan—Hypersensitivity—Cabazitaxel—prostate cancer	0.000162	0.00382	CcSEcCtD
Dextromethorphan—Mental disorder—Goserelin—prostate cancer	0.000162	0.00381	CcSEcCtD
Dextromethorphan—Constipation—Bicalutamide—prostate cancer	0.000161	0.0038	CcSEcCtD
Dextromethorphan—Mental disorder—Conjugated Estrogens—prostate cancer	0.00016	0.00377	CcSEcCtD
Dextromethorphan—SLC6A2—testis—prostate cancer	0.00016	0.00736	CbGeAlD
Dextromethorphan—Diarrhoea—Degarelix—prostate cancer	0.00016	0.00376	CcSEcCtD
Dextromethorphan—Tension—Goserelin—prostate cancer	0.000158	0.00372	CcSEcCtD
Dextromethorphan—Asthenia—Cabazitaxel—prostate cancer	0.000158	0.00372	CcSEcCtD
Dextromethorphan—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000157	0.00368	CcSEcCtD
Dextromethorphan—Tension—Conjugated Estrogens—prostate cancer	0.000156	0.00368	CcSEcCtD
Dextromethorphan—Nervousness—Goserelin—prostate cancer	0.000156	0.00368	CcSEcCtD
Dextromethorphan—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000156	0.00368	CcSEcCtD
Dextromethorphan—Feeling abnormal—Bicalutamide—prostate cancer	0.000156	0.00366	CcSEcCtD
Dextromethorphan—Nausea—Nilutamide—prostate cancer	0.000155	0.00366	CcSEcCtD
Dextromethorphan—Nervousness—Conjugated Estrogens—prostate cancer	0.000155	0.00364	CcSEcCtD
Dextromethorphan—Nausea—Flutamide—prostate cancer	0.000155	0.00364	CcSEcCtD
Dextromethorphan—Dizziness—Degarelix—prostate cancer	0.000155	0.00364	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Bicalutamide—prostate cancer	0.000154	0.00363	CcSEcCtD
Dextromethorphan—Drowsiness—Mitoxantrone—prostate cancer	0.000152	0.00358	CcSEcCtD
Dextromethorphan—Codeine—CYP3A5—prostate cancer	0.000152	0.157	CrCbGaD
Dextromethorphan—Diarrhoea—Cabazitaxel—prostate cancer	0.000151	0.00354	CcSEcCtD
Dextromethorphan—Abdominal pain—Bicalutamide—prostate cancer	0.000149	0.00351	CcSEcCtD
Dextromethorphan—Vomiting—Degarelix—prostate cancer	0.000149	0.0035	CcSEcCtD
Dextromethorphan—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000146	0.00343	CcSEcCtD
Dextromethorphan—Dizziness—Cabazitaxel—prostate cancer	0.000146	0.00342	CcSEcCtD
Dextromethorphan—ABCB1—prostate gland—prostate cancer	0.000143	0.00658	CbGeAlD
Dextromethorphan—Vomiting—Cabazitaxel—prostate cancer	0.00014	0.00329	CcSEcCtD
Dextromethorphan—Hypersensitivity—Bicalutamide—prostate cancer	0.000139	0.00327	CcSEcCtD
Dextromethorphan—Nausea—Degarelix—prostate cancer	0.000139	0.00327	CcSEcCtD
Dextromethorphan—CYP3A4—renal system—prostate cancer	0.000138	0.00634	CbGeAlD
Dextromethorphan—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000138	0.00324	CcSEcCtD
Dextromethorphan—Fatigue—Ethinyl Estradiol—prostate cancer	0.000138	0.00324	CcSEcCtD
Dextromethorphan—Constipation—Ethinyl Estradiol—prostate cancer	0.000137	0.00321	CcSEcCtD
Dextromethorphan—CYP2D6—renal system—prostate cancer	0.000136	0.00624	CbGeAlD
Dextromethorphan—Asthenia—Bicalutamide—prostate cancer	0.000135	0.00319	CcSEcCtD
Dextromethorphan—Confusional state—Goserelin—prostate cancer	0.000132	0.00312	CcSEcCtD
Dextromethorphan—Immune system disorder—Estradiol—prostate cancer	0.000132	0.00311	CcSEcCtD
Dextromethorphan—CYP2C8—testis—prostate cancer	0.000132	0.00605	CbGeAlD
Dextromethorphan—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000132	0.00309	CcSEcCtD
Dextromethorphan—SIGMAR1—lymph node—prostate cancer	0.000131	0.00602	CbGeAlD
Dextromethorphan—Nausea—Cabazitaxel—prostate cancer	0.000131	0.00308	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000131	0.00307	CcSEcCtD
Dextromethorphan—Diarrhoea—Bicalutamide—prostate cancer	0.000129	0.00304	CcSEcCtD
Dextromethorphan—Nervous system disorder—Goserelin—prostate cancer	0.000129	0.00303	CcSEcCtD
Dextromethorphan—Mental disorder—Estradiol—prostate cancer	0.000128	0.00302	CcSEcCtD
Dextromethorphan—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000128	0.003	CcSEcCtD
Dextromethorphan—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000126	0.00297	CcSEcCtD
Dextromethorphan—Irritability—Capecitabine—prostate cancer	0.000126	0.00297	CcSEcCtD
Dextromethorphan—Tension—Estradiol—prostate cancer	0.000125	0.00295	CcSEcCtD
Dextromethorphan—Dizziness—Bicalutamide—prostate cancer	0.000125	0.00294	CcSEcCtD
Dextromethorphan—Nervousness—Estradiol—prostate cancer	0.000124	0.00292	CcSEcCtD
Dextromethorphan—ABCB1—seminal vesicle—prostate cancer	0.000121	0.00557	CbGeAlD
Dextromethorphan—Tramadol—CYP3A4—prostate cancer	0.00012	0.124	CrCbGaD
Dextromethorphan—Vomiting—Bicalutamide—prostate cancer	0.00012	0.00282	CcSEcCtD
Dextromethorphan—CYP2B6—testis—prostate cancer	0.000118	0.00543	CbGeAlD
Dextromethorphan—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000118	0.00277	CcSEcCtD
Dextromethorphan—Agitation—Estradiol—prostate cancer	0.000117	0.00276	CcSEcCtD
Dextromethorphan—Somnolence—Goserelin—prostate cancer	0.000117	0.00275	CcSEcCtD
Dextromethorphan—SLC6A2—lymph node—prostate cancer	0.000116	0.00534	CbGeAlD
Dextromethorphan—Somnolence—Conjugated Estrogens—prostate cancer	0.000116	0.00272	CcSEcCtD
Dextromethorphan—Dyspepsia—Goserelin—prostate cancer	0.000116	0.00272	CcSEcCtD
Dextromethorphan—Psychotic disorder—Prednisone—prostate cancer	0.000115	0.0027	CcSEcCtD
Dextromethorphan—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000115	0.00269	CcSEcCtD
Dextromethorphan—Asthenia—Ethinyl Estradiol—prostate cancer	0.000115	0.00269	CcSEcCtD
Dextromethorphan—Fatigue—Goserelin—prostate cancer	0.000113	0.00266	CcSEcCtD
Dextromethorphan—Irritability—Prednisone—prostate cancer	0.000112	0.00264	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000112	0.00264	CcSEcCtD
Dextromethorphan—Constipation—Goserelin—prostate cancer	0.000112	0.00264	CcSEcCtD
Dextromethorphan—Fatigue—Conjugated Estrogens—prostate cancer	0.000112	0.00264	CcSEcCtD
Dextromethorphan—Nausea—Bicalutamide—prostate cancer	0.000112	0.00264	CcSEcCtD
Dextromethorphan—Constipation—Conjugated Estrogens—prostate cancer	0.000111	0.00262	CcSEcCtD
Dextromethorphan—CYP2E1—testis—prostate cancer	0.000111	0.00509	CbGeAlD
Dextromethorphan—Abdominal discomfort—Capecitabine—prostate cancer	0.000109	0.00258	CcSEcCtD
Dextromethorphan—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000109	0.00257	CcSEcCtD
Dextromethorphan—Feeling abnormal—Goserelin—prostate cancer	0.000108	0.00255	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Goserelin—prostate cancer	0.000107	0.00253	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000106	0.0025	CcSEcCtD
Dextromethorphan—Dizziness—Ethinyl Estradiol—prostate cancer	0.000106	0.00248	CcSEcCtD
Dextromethorphan—ABCB1—epithelium—prostate cancer	0.000105	0.00484	CbGeAlD
Dextromethorphan—Confusional state—Estradiol—prostate cancer	0.000105	0.00247	CcSEcCtD
Dextromethorphan—Abdominal pain—Goserelin—prostate cancer	0.000104	0.00244	CcSEcCtD
Dextromethorphan—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000103	0.00242	CcSEcCtD
Dextromethorphan—Immune system disorder—Etoposide—prostate cancer	0.000103	0.00241	CcSEcCtD
Dextromethorphan—Nervous system disorder—Estradiol—prostate cancer	0.000102	0.0024	CcSEcCtD
Dextromethorphan—Vomiting—Ethinyl Estradiol—prostate cancer	0.000101	0.00239	CcSEcCtD
Dextromethorphan—Dihydrocodeine—CYP3A4—prostate cancer	9.87e-05	0.102	CrCbGaD
Dextromethorphan—Confusional state—Mitoxantrone—prostate cancer	9.78e-05	0.0023	CcSEcCtD
Dextromethorphan—ABCB1—renal system—prostate cancer	9.77e-05	0.00449	CbGeAlD
Dextromethorphan—Hypersensitivity—Goserelin—prostate cancer	9.68e-05	0.00228	CcSEcCtD
Dextromethorphan—ABCB1—urethra—prostate cancer	9.59e-05	0.00441	CbGeAlD
Dextromethorphan—Hypersensitivity—Conjugated Estrogens—prostate cancer	9.59e-05	0.00226	CcSEcCtD
Dextromethorphan—Nausea—Ethinyl Estradiol—prostate cancer	9.48e-05	0.00223	CcSEcCtD
Dextromethorphan—Hypoglycaemia—Epirubicin—prostate cancer	9.43e-05	0.00222	CcSEcCtD
Dextromethorphan—Asthenia—Goserelin—prostate cancer	9.43e-05	0.00222	CcSEcCtD
Dextromethorphan—Asthenia—Conjugated Estrogens—prostate cancer	9.34e-05	0.0022	CcSEcCtD
Dextromethorphan—Somnolence—Estradiol—prostate cancer	9.26e-05	0.00218	CcSEcCtD
Dextromethorphan—Dyspepsia—Estradiol—prostate cancer	9.17e-05	0.00216	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Estradiol—prostate cancer	8.99e-05	0.00212	CcSEcCtD
Dextromethorphan—Diarrhoea—Goserelin—prostate cancer	8.99e-05	0.00211	CcSEcCtD
Dextromethorphan—Fatigue—Estradiol—prostate cancer	8.98e-05	0.00211	CcSEcCtD
Dextromethorphan—Constipation—Estradiol—prostate cancer	8.91e-05	0.00209	CcSEcCtD
Dextromethorphan—Diarrhoea—Conjugated Estrogens—prostate cancer	8.9e-05	0.00209	CcSEcCtD
Dextromethorphan—CYP2D6—testis—prostate cancer	8.77e-05	0.00403	CbGeAlD
Dextromethorphan—Hypoglycaemia—Doxorubicin—prostate cancer	8.73e-05	0.00205	CcSEcCtD
Dextromethorphan—Dizziness—Goserelin—prostate cancer	8.69e-05	0.00204	CcSEcCtD
Dextromethorphan—Somnolence—Mitoxantrone—prostate cancer	8.63e-05	0.00203	CcSEcCtD
Dextromethorphan—Dizziness—Conjugated Estrogens—prostate cancer	8.61e-05	0.00202	CcSEcCtD
Dextromethorphan—Feeling abnormal—Estradiol—prostate cancer	8.58e-05	0.00202	CcSEcCtD
Dextromethorphan—Dyspepsia—Mitoxantrone—prostate cancer	8.54e-05	0.00201	CcSEcCtD
Dextromethorphan—Immune system disorder—Docetaxel—prostate cancer	8.53e-05	0.00201	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Estradiol—prostate cancer	8.52e-05	0.002	CcSEcCtD
Dextromethorphan—Fatigue—Mitoxantrone—prostate cancer	8.37e-05	0.00197	CcSEcCtD
Dextromethorphan—Vomiting—Goserelin—prostate cancer	8.35e-05	0.00196	CcSEcCtD
Dextromethorphan—Constipation—Mitoxantrone—prostate cancer	8.3e-05	0.00195	CcSEcCtD
Dextromethorphan—Vomiting—Conjugated Estrogens—prostate cancer	8.27e-05	0.00195	CcSEcCtD
Dextromethorphan—Mental disorder—Docetaxel—prostate cancer	8.27e-05	0.00195	CcSEcCtD
Dextromethorphan—Immune system disorder—Capecitabine—prostate cancer	8.26e-05	0.00194	CcSEcCtD
Dextromethorphan—Abdominal pain—Estradiol—prostate cancer	8.23e-05	0.00194	CcSEcCtD
Dextromethorphan—Confusional state—Etoposide—prostate cancer	8.14e-05	0.00191	CcSEcCtD
Dextromethorphan—Hallucination—Prednisone—prostate cancer	8.1e-05	0.00191	CcSEcCtD
Dextromethorphan—Mental disorder—Capecitabine—prostate cancer	8.01e-05	0.00188	CcSEcCtD
Dextromethorphan—Feeling abnormal—Mitoxantrone—prostate cancer	8e-05	0.00188	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Mitoxantrone—prostate cancer	7.94e-05	0.00187	CcSEcCtD
Dextromethorphan—Nausea—Goserelin—prostate cancer	7.8e-05	0.00184	CcSEcCtD
Dextromethorphan—Nausea—Conjugated Estrogens—prostate cancer	7.73e-05	0.00182	CcSEcCtD
Dextromethorphan—Hypersensitivity—Estradiol—prostate cancer	7.67e-05	0.0018	CcSEcCtD
Dextromethorphan—Abdominal pain—Mitoxantrone—prostate cancer	7.67e-05	0.0018	CcSEcCtD
Dextromethorphan—Hydrocodone—CYP3A4—prostate cancer	7.56e-05	0.0783	CrCbGaD
Dextromethorphan—Asthenia—Estradiol—prostate cancer	7.47e-05	0.00176	CcSEcCtD
Dextromethorphan—ABCB1—bone marrow—prostate cancer	7.38e-05	0.00339	CbGeAlD
Dextromethorphan—Immune system disorder—Prednisone—prostate cancer	7.36e-05	0.00173	CcSEcCtD
Dextromethorphan—Somnolence—Etoposide—prostate cancer	7.18e-05	0.00169	CcSEcCtD
Dextromethorphan—Hypersensitivity—Mitoxantrone—prostate cancer	7.15e-05	0.00168	CcSEcCtD
Dextromethorphan—Mental disorder—Prednisone—prostate cancer	7.13e-05	0.00168	CcSEcCtD
Dextromethorphan—Diarrhoea—Estradiol—prostate cancer	7.13e-05	0.00168	CcSEcCtD
Dextromethorphan—Drowsiness—Epirubicin—prostate cancer	7.09e-05	0.00167	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Etoposide—prostate cancer	6.97e-05	0.00164	CcSEcCtD
Dextromethorphan—Asthenia—Mitoxantrone—prostate cancer	6.96e-05	0.00164	CcSEcCtD
Dextromethorphan—Fatigue—Etoposide—prostate cancer	6.96e-05	0.00164	CcSEcCtD
Dextromethorphan—Constipation—Etoposide—prostate cancer	6.9e-05	0.00162	CcSEcCtD
Dextromethorphan—Dizziness—Estradiol—prostate cancer	6.89e-05	0.00162	CcSEcCtD
Dextromethorphan—Confusional state—Docetaxel—prostate cancer	6.76e-05	0.00159	CcSEcCtD
Dextromethorphan—Feeling abnormal—Etoposide—prostate cancer	6.65e-05	0.00156	CcSEcCtD
Dextromethorphan—Diarrhoea—Mitoxantrone—prostate cancer	6.64e-05	0.00156	CcSEcCtD
Dextromethorphan—Vomiting—Estradiol—prostate cancer	6.62e-05	0.00156	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Etoposide—prostate cancer	6.6e-05	0.00155	CcSEcCtD
Dextromethorphan—Codeine—CYP3A4—prostate cancer	6.58e-05	0.0681	CrCbGaD
Dextromethorphan—Nervous system disorder—Docetaxel—prostate cancer	6.58e-05	0.00155	CcSEcCtD
Dextromethorphan—Drowsiness—Doxorubicin—prostate cancer	6.56e-05	0.00154	CcSEcCtD
Dextromethorphan—Confusional state—Capecitabine—prostate cancer	6.55e-05	0.00154	CcSEcCtD
Dextromethorphan—Agitation—Prednisone—prostate cancer	6.51e-05	0.00153	CcSEcCtD
Dextromethorphan—Abdominal pain—Etoposide—prostate cancer	6.38e-05	0.0015	CcSEcCtD
Dextromethorphan—Nervous system disorder—Capecitabine—prostate cancer	6.37e-05	0.0015	CcSEcCtD
Dextromethorphan—ABCB1—testis—prostate cancer	6.31e-05	0.0029	CbGeAlD
Dextromethorphan—Hydromorphone—CYP3A4—prostate cancer	6.27e-05	0.0648	CrCbGaD
Dextromethorphan—Nausea—Estradiol—prostate cancer	6.19e-05	0.00146	CcSEcCtD
Dextromethorphan—Vomiting—Mitoxantrone—prostate cancer	6.17e-05	0.00145	CcSEcCtD
Dextromethorphan—Somnolence—Docetaxel—prostate cancer	5.96e-05	0.0014	CcSEcCtD
Dextromethorphan—Hypersensitivity—Etoposide—prostate cancer	5.95e-05	0.0014	CcSEcCtD
Dextromethorphan—Dyspepsia—Docetaxel—prostate cancer	5.9e-05	0.00139	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Docetaxel—prostate cancer	5.79e-05	0.00136	CcSEcCtD
Dextromethorphan—Asthenia—Etoposide—prostate cancer	5.79e-05	0.00136	CcSEcCtD
Dextromethorphan—Fatigue—Docetaxel—prostate cancer	5.78e-05	0.00136	CcSEcCtD
Dextromethorphan—Nausea—Mitoxantrone—prostate cancer	5.76e-05	0.00136	CcSEcCtD
Dextromethorphan—Immune system disorder—Epirubicin—prostate cancer	5.75e-05	0.00135	CcSEcCtD
Dextromethorphan—Constipation—Docetaxel—prostate cancer	5.74e-05	0.00135	CcSEcCtD
Dextromethorphan—Dyspepsia—Capecitabine—prostate cancer	5.72e-05	0.00134	CcSEcCtD
Dextromethorphan—Nervous system disorder—Prednisone—prostate cancer	5.67e-05	0.00133	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Capecitabine—prostate cancer	5.61e-05	0.00132	CcSEcCtD
Dextromethorphan—Fatigue—Capecitabine—prostate cancer	5.6e-05	0.00132	CcSEcCtD
Dextromethorphan—Mental disorder—Epirubicin—prostate cancer	5.58e-05	0.00131	CcSEcCtD
Dextromethorphan—Constipation—Capecitabine—prostate cancer	5.55e-05	0.00131	CcSEcCtD
Dextromethorphan—Feeling abnormal—Docetaxel—prostate cancer	5.53e-05	0.0013	CcSEcCtD
Dextromethorphan—Diarrhoea—Etoposide—prostate cancer	5.52e-05	0.0013	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Docetaxel—prostate cancer	5.49e-05	0.00129	CcSEcCtD
Dextromethorphan—Tension—Epirubicin—prostate cancer	5.44e-05	0.00128	CcSEcCtD
Dextromethorphan—Nervousness—Epirubicin—prostate cancer	5.38e-05	0.00127	CcSEcCtD
Dextromethorphan—Feeling abnormal—Capecitabine—prostate cancer	5.35e-05	0.00126	CcSEcCtD
Dextromethorphan—Dizziness—Etoposide—prostate cancer	5.34e-05	0.00126	CcSEcCtD
Dextromethorphan—Immune system disorder—Doxorubicin—prostate cancer	5.32e-05	0.00125	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Capecitabine—prostate cancer	5.31e-05	0.00125	CcSEcCtD
Dextromethorphan—Abdominal pain—Docetaxel—prostate cancer	5.3e-05	0.00125	CcSEcCtD
Dextromethorphan—Mental disorder—Doxorubicin—prostate cancer	5.16e-05	0.00121	CcSEcCtD
Dextromethorphan—Abdominal pain—Capecitabine—prostate cancer	5.13e-05	0.00121	CcSEcCtD
Dextromethorphan—Vomiting—Etoposide—prostate cancer	5.13e-05	0.00121	CcSEcCtD
Dextromethorphan—Agitation—Epirubicin—prostate cancer	5.09e-05	0.0012	CcSEcCtD
Dextromethorphan—Dyspepsia—Prednisone—prostate cancer	5.09e-05	0.0012	CcSEcCtD
Dextromethorphan—Tension—Doxorubicin—prostate cancer	5.03e-05	0.00118	CcSEcCtD
Dextromethorphan—Fatigue—Prednisone—prostate cancer	4.99e-05	0.00117	CcSEcCtD
Dextromethorphan—Nervousness—Doxorubicin—prostate cancer	4.98e-05	0.00117	CcSEcCtD
Dextromethorphan—Constipation—Prednisone—prostate cancer	4.95e-05	0.00116	CcSEcCtD
Dextromethorphan—Hypersensitivity—Docetaxel—prostate cancer	4.94e-05	0.00116	CcSEcCtD
Dextromethorphan—Asthenia—Docetaxel—prostate cancer	4.81e-05	0.00113	CcSEcCtD
Dextromethorphan—Nausea—Etoposide—prostate cancer	4.79e-05	0.00113	CcSEcCtD
Dextromethorphan—Hypersensitivity—Capecitabine—prostate cancer	4.79e-05	0.00113	CcSEcCtD
Dextromethorphan—Feeling abnormal—Prednisone—prostate cancer	4.77e-05	0.00112	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Prednisone—prostate cancer	4.73e-05	0.00111	CcSEcCtD
Dextromethorphan—Agitation—Doxorubicin—prostate cancer	4.71e-05	0.00111	CcSEcCtD
Dextromethorphan—Asthenia—Capecitabine—prostate cancer	4.66e-05	0.0011	CcSEcCtD
Dextromethorphan—Diarrhoea—Docetaxel—prostate cancer	4.59e-05	0.00108	CcSEcCtD
Dextromethorphan—ABCB1—lymph node—prostate cancer	4.58e-05	0.0021	CbGeAlD
Dextromethorphan—Abdominal pain—Prednisone—prostate cancer	4.57e-05	0.00108	CcSEcCtD
Dextromethorphan—Confusional state—Epirubicin—prostate cancer	4.56e-05	0.00107	CcSEcCtD
Dextromethorphan—Diarrhoea—Capecitabine—prostate cancer	4.44e-05	0.00105	CcSEcCtD
Dextromethorphan—Nervous system disorder—Epirubicin—prostate cancer	4.44e-05	0.00104	CcSEcCtD
Dextromethorphan—Dizziness—Docetaxel—prostate cancer	4.44e-05	0.00104	CcSEcCtD
Dextromethorphan—Dizziness—Capecitabine—prostate cancer	4.29e-05	0.00101	CcSEcCtD
Dextromethorphan—Vomiting—Docetaxel—prostate cancer	4.27e-05	0.001	CcSEcCtD
Dextromethorphan—Hypersensitivity—Prednisone—prostate cancer	4.26e-05	0.001	CcSEcCtD
Dextromethorphan—Confusional state—Doxorubicin—prostate cancer	4.22e-05	0.000993	CcSEcCtD
Dextromethorphan—Asthenia—Prednisone—prostate cancer	4.15e-05	0.000976	CcSEcCtD
Dextromethorphan—Vomiting—Capecitabine—prostate cancer	4.13e-05	0.000971	CcSEcCtD
Dextromethorphan—Nervous system disorder—Doxorubicin—prostate cancer	4.11e-05	0.000966	CcSEcCtD
Dextromethorphan—Somnolence—Epirubicin—prostate cancer	4.02e-05	0.000946	CcSEcCtD
Dextromethorphan—Nausea—Docetaxel—prostate cancer	3.98e-05	0.000937	CcSEcCtD
Dextromethorphan—Dyspepsia—Epirubicin—prostate cancer	3.98e-05	0.000937	CcSEcCtD
Dextromethorphan—Diarrhoea—Prednisone—prostate cancer	3.96e-05	0.000931	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Epirubicin—prostate cancer	3.91e-05	0.000919	CcSEcCtD
Dextromethorphan—Fatigue—Epirubicin—prostate cancer	3.9e-05	0.000918	CcSEcCtD
Dextromethorphan—Constipation—Epirubicin—prostate cancer	3.87e-05	0.00091	CcSEcCtD
Dextromethorphan—Nausea—Capecitabine—prostate cancer	3.86e-05	0.000907	CcSEcCtD
Dextromethorphan—Dizziness—Prednisone—prostate cancer	3.83e-05	0.0009	CcSEcCtD
Dextromethorphan—Feeling abnormal—Epirubicin—prostate cancer	3.73e-05	0.000877	CcSEcCtD
Dextromethorphan—Somnolence—Doxorubicin—prostate cancer	3.72e-05	0.000875	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Epirubicin—prostate cancer	3.7e-05	0.00087	CcSEcCtD
Dextromethorphan—Dyspepsia—Doxorubicin—prostate cancer	3.69e-05	0.000867	CcSEcCtD
Dextromethorphan—Vomiting—Prednisone—prostate cancer	3.68e-05	0.000865	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.61e-05	0.00085	CcSEcCtD
Dextromethorphan—Fatigue—Doxorubicin—prostate cancer	3.61e-05	0.000849	CcSEcCtD
Dextromethorphan—Constipation—Doxorubicin—prostate cancer	3.58e-05	0.000842	CcSEcCtD
Dextromethorphan—Abdominal pain—Epirubicin—prostate cancer	3.58e-05	0.000841	CcSEcCtD
Dextromethorphan—Feeling abnormal—Doxorubicin—prostate cancer	3.45e-05	0.000812	CcSEcCtD
Dextromethorphan—Nausea—Prednisone—prostate cancer	3.44e-05	0.000808	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Doxorubicin—prostate cancer	3.42e-05	0.000805	CcSEcCtD
Dextromethorphan—Hypersensitivity—Epirubicin—prostate cancer	3.33e-05	0.000784	CcSEcCtD
Dextromethorphan—Abdominal pain—Doxorubicin—prostate cancer	3.31e-05	0.000778	CcSEcCtD
Dextromethorphan—Asthenia—Epirubicin—prostate cancer	3.25e-05	0.000764	CcSEcCtD
Dextromethorphan—Diarrhoea—Epirubicin—prostate cancer	3.1e-05	0.000728	CcSEcCtD
Dextromethorphan—Hypersensitivity—Doxorubicin—prostate cancer	3.08e-05	0.000726	CcSEcCtD
Dextromethorphan—Asthenia—Doxorubicin—prostate cancer	3e-05	0.000707	CcSEcCtD
Dextromethorphan—Dizziness—Epirubicin—prostate cancer	2.99e-05	0.000704	CcSEcCtD
Dextromethorphan—Vomiting—Epirubicin—prostate cancer	2.88e-05	0.000677	CcSEcCtD
Dextromethorphan—Diarrhoea—Doxorubicin—prostate cancer	2.86e-05	0.000674	CcSEcCtD
Dextromethorphan—Dizziness—Doxorubicin—prostate cancer	2.77e-05	0.000651	CcSEcCtD
Dextromethorphan—Nausea—Epirubicin—prostate cancer	2.69e-05	0.000632	CcSEcCtD
Dextromethorphan—Vomiting—Doxorubicin—prostate cancer	2.66e-05	0.000626	CcSEcCtD
Dextromethorphan—Nausea—Doxorubicin—prostate cancer	2.49e-05	0.000585	CcSEcCtD
Dextromethorphan—CYP3A4—Metabolism—MED12—prostate cancer	9.29e-07	1.67e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—COMT—prostate cancer	9.29e-07	1.66e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—GSTP1—prostate cancer	9.24e-07	1.66e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—CYP1A1—prostate cancer	9.24e-07	1.66e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—GNG5—prostate cancer	9.22e-07	1.65e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—CAV1—prostate cancer	9.2e-07	1.65e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—CAV1—prostate cancer	9.18e-07	1.64e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—ERCC2—prostate cancer	9.17e-07	1.64e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.16e-07	1.64e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—CCND1—prostate cancer	9.13e-07	1.64e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—ITPR1—prostate cancer	9.1e-07	1.63e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—RXRA—prostate cancer	9.09e-07	1.63e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—VEGFA—prostate cancer	9.07e-07	1.63e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—JAK2—prostate cancer	9.07e-07	1.63e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	9.04e-07	1.62e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—RXRA—prostate cancer	9.01e-07	1.61e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—STAT3—prostate cancer	8.98e-07	1.61e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	8.89e-07	1.59e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—NCOA3—prostate cancer	8.88e-07	1.59e-05	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—PIK3CB—prostate cancer	8.86e-07	1.59e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—MMP9—prostate cancer	8.86e-07	1.59e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—MDM2—prostate cancer	8.85e-07	1.59e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	8.83e-07	1.58e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—PTEN—prostate cancer	8.81e-07	1.58e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—TYMS—prostate cancer	8.81e-07	1.58e-05	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—PTGS2—prostate cancer	8.78e-07	1.57e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.76e-07	1.57e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—COMT—prostate cancer	8.75e-07	1.57e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—ERBB2—prostate cancer	8.73e-07	1.56e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—GSTP1—prostate cancer	8.71e-07	1.56e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—GSTM1—prostate cancer	8.7e-07	1.56e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—COMT—prostate cancer	8.68e-07	1.55e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—GSTP1—prostate cancer	8.64e-07	1.55e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—MTHFR—prostate cancer	8.62e-07	1.54e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	8.62e-07	1.54e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—TYMS—prostate cancer	8.59e-07	1.54e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling by GPCR—AKT1—prostate cancer	8.59e-07	1.54e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—ITPR1—prostate cancer	8.57e-07	1.54e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PIK3CG—prostate cancer	8.55e-07	1.53e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—LPL—prostate cancer	8.54e-07	1.53e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—ITPR1—prostate cancer	8.5e-07	1.52e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—GSTM1—prostate cancer	8.49e-07	1.52e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—HPGDS—prostate cancer	8.47e-07	1.52e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PPARA—prostate cancer	8.45e-07	1.52e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP2C19—prostate cancer	8.42e-07	1.51e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—EP300—prostate cancer	8.4e-07	1.51e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PIK3CG—prostate cancer	8.38e-07	1.5e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PIK3CG—prostate cancer	8.36e-07	1.5e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.36e-07	1.5e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—MYC—prostate cancer	8.35e-07	1.5e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—LPL—prostate cancer	8.34e-07	1.49e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—TGFB1—prostate cancer	8.33e-07	1.49e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CXCL8—prostate cancer	8.28e-07	1.48e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—CYP1A1—prostate cancer	8.25e-07	1.48e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—ACHE—prostate cancer	8.22e-07	1.47e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—GSTT1—prostate cancer	8.22e-07	1.47e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—ERCC2—prostate cancer	8.18e-07	1.47e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—SRC—prostate cancer	8.17e-07	1.46e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—EGFR—prostate cancer	8.17e-07	1.46e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.12e-07	1.46e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—TYMS—prostate cancer	8.1e-07	1.45e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—INS—prostate cancer	8.1e-07	1.45e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	8.08e-07	1.45e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—CYP1A1—prostate cancer	8.05e-07	1.44e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—TYMS—prostate cancer	8.03e-07	1.44e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—GSTM1—prostate cancer	8.01e-07	1.43e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	8e-07	1.43e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—ERCC2—prostate cancer	7.99e-07	1.43e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—VEGFA—prostate cancer	7.96e-07	1.43e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—CAV1—prostate cancer	7.95e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—GSTM1—prostate cancer	7.94e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—CREBBP—prostate cancer	7.93e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—INS—prostate cancer	7.93e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CASP3—prostate cancer	7.92e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—INS—prostate cancer	7.91e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—IL2—prostate cancer	7.91e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.9e-07	1.42e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—STAT3—prostate cancer	7.88e-07	1.41e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—IL6—prostate cancer	7.87e-07	1.41e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PRKACB—prostate cancer	7.86e-07	1.41e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—LPL—prostate cancer	7.86e-07	1.41e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—LPL—prostate cancer	7.79e-07	1.4e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.78e-07	1.39e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—CREBBP—prostate cancer	7.77e-07	1.39e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—CREBBP—prostate cancer	7.75e-07	1.39e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—KRAS—prostate cancer	7.71e-07	1.38e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CCND1—prostate cancer	7.71e-07	1.38e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—MTHFR—prostate cancer	7.69e-07	1.38e-05	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—PTEN—prostate cancer	7.66e-07	1.37e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	7.64e-07	1.37e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.59e-07	1.36e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—CYP1A1—prostate cancer	7.59e-07	1.36e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PPARA—prostate cancer	7.55e-07	1.35e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—ERCC2—prostate cancer	7.53e-07	1.35e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—CYP1A1—prostate cancer	7.52e-07	1.35e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PIK3CD—prostate cancer	7.52e-07	1.35e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—MTHFR—prostate cancer	7.51e-07	1.35e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—MMP9—prostate cancer	7.49e-07	1.34e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—ERCC2—prostate cancer	7.46e-07	1.34e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	7.46e-07	1.34e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—PTEN—prostate cancer	7.44e-07	1.33e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—NCOA2—prostate cancer	7.41e-07	1.33e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PPARA—prostate cancer	7.37e-07	1.32e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PIK3CD—prostate cancer	7.36e-07	1.32e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PIK3CD—prostate cancer	7.35e-07	1.32e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—MYC—prostate cancer	7.32e-07	1.31e-05	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—EP300—prostate cancer	7.3e-07	1.31e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—TGFB1—prostate cancer	7.3e-07	1.31e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—AKT1—prostate cancer	7.26e-07	1.3e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PIK3CG—prostate cancer	7.24e-07	1.3e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—EGFR—prostate cancer	7.16e-07	1.28e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—EP300—prostate cancer	7.1e-07	1.27e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—NOS3—prostate cancer	7.1e-07	1.27e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—CAV1—prostate cancer	7.1e-07	1.27e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	7.09e-07	1.27e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—MTHFR—prostate cancer	7.07e-07	1.27e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.07e-07	1.27e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—MTHFR—prostate cancer	7.01e-07	1.26e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—NOS3—prostate cancer	6.95e-07	1.25e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PPARA—prostate cancer	6.94e-07	1.24e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—NOS3—prostate cancer	6.94e-07	1.24e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—CAV1—prostate cancer	6.93e-07	1.24e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.91e-07	1.24e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—SRC—prostate cancer	6.9e-07	1.24e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PPARA—prostate cancer	6.88e-07	1.23e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—TP53—prostate cancer	6.86e-07	1.23e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—INS—prostate cancer	6.85e-07	1.23e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—NQO1—prostate cancer	6.83e-07	1.22e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.78e-07	1.21e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—KRAS—prostate cancer	6.76e-07	1.21e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—TH—prostate cancer	6.73e-07	1.21e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—VEGFA—prostate cancer	6.72e-07	1.2e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—CREBBP—prostate cancer	6.71e-07	1.2e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—STAT3—prostate cancer	6.66e-07	1.19e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PIK3CB—prostate cancer	6.55e-07	1.17e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.55e-07	1.17e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—CAV1—prostate cancer	6.53e-07	1.17e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PTGS2—prostate cancer	6.49e-07	1.16e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—CAV1—prostate cancer	6.47e-07	1.16e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PIK3CG—prostate cancer	6.46e-07	1.16e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PIK3CB—prostate cancer	6.42e-07	1.15e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PIK3CB—prostate cancer	6.41e-07	1.15e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PIK3CD—prostate cancer	6.37e-07	1.14e-05	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PTGS2—prostate cancer	6.36e-07	1.14e-05	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PTGS2—prostate cancer	6.35e-07	1.14e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—GGT1—prostate cancer	6.34e-07	1.14e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PIK3CG—prostate cancer	6.31e-07	1.13e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—IL6—prostate cancer	6.28e-07	1.12e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—NCOA1—prostate cancer	6.25e-07	1.12e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	6.21e-07	1.11e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—MYC—prostate cancer	6.19e-07	1.11e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.18e-07	1.11e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—TGFB1—prostate cancer	6.17e-07	1.11e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.16e-07	1.1e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—INS—prostate cancer	6.12e-07	1.1e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—EGFR—prostate cancer	6.05e-07	1.08e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—TP53—prostate cancer	6.01e-07	1.08e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—NOS3—prostate cancer	6.01e-07	1.08e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—CREBBP—prostate cancer	5.99e-07	1.07e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—INS—prostate cancer	5.97e-07	1.07e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PIK3CG—prostate cancer	5.94e-07	1.07e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—RXRA—prostate cancer	5.94e-07	1.06e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PIK3CG—prostate cancer	5.89e-07	1.06e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—CREBBP—prostate cancer	5.85e-07	1.05e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—AKT1—prostate cancer	5.79e-07	1.04e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—COMT—prostate cancer	5.72e-07	1.03e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—KRAS—prostate cancer	5.72e-07	1.02e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—GSTP1—prostate cancer	5.7e-07	1.02e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PIK3CD—prostate cancer	5.68e-07	1.02e-05	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PTEN—prostate cancer	5.66e-07	1.01e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—INS—prostate cancer	5.63e-07	1.01e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—ITPR1—prostate cancer	5.6e-07	1e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—INS—prostate cancer	5.58e-07	1e-05	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.55e-07	9.94e-06	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PTEN—prostate cancer	5.55e-07	9.94e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PIK3CD—prostate cancer	5.55e-07	9.94e-06	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PTEN—prostate cancer	5.53e-07	9.92e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—CREBBP—prostate cancer	5.51e-07	9.88e-06	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—IL6—prostate cancer	5.5e-07	9.86e-06	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PTGS2—prostate cancer	5.5e-07	9.85e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—CREBBP—prostate cancer	5.46e-07	9.79e-06	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—PIK3CA—prostate cancer	5.4e-07	9.68e-06	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—EP300—prostate cancer	5.4e-07	9.68e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—NOS3—prostate cancer	5.36e-07	9.61e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—TYMS—prostate cancer	5.29e-07	9.49e-06	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—EP300—prostate cancer	5.29e-07	9.48e-06	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—EP300—prostate cancer	5.28e-07	9.46e-06	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	5.25e-07	9.41e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—NOS3—prostate cancer	5.24e-07	9.38e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—GSTM1—prostate cancer	5.23e-07	9.38e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.23e-07	9.36e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.18e-07	9.28e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—LPL—prostate cancer	5.14e-07	9.21e-06	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—TP53—prostate cancer	5.08e-07	9.1e-06	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—AKT1—prostate cancer	5.08e-07	9.1e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.96e-07	8.89e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PIK3CB—prostate cancer	4.95e-07	8.87e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—NOS3—prostate cancer	4.93e-07	8.84e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—ERCC2—prostate cancer	4.92e-07	8.82e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PTGS2—prostate cancer	4.91e-07	8.79e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—NOS3—prostate cancer	4.89e-07	8.77e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PIK3CB—prostate cancer	4.83e-07	8.66e-06	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PTEN—prostate cancer	4.79e-07	8.59e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PTGS2—prostate cancer	4.79e-07	8.58e-06	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—IL6—prostate cancer	4.65e-07	8.33e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—MTHFR—prostate cancer	4.63e-07	8.29e-06	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—EP300—prostate cancer	4.57e-07	8.19e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.55e-07	8.16e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PPARA—prostate cancer	4.54e-07	8.13e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PIK3CB—prostate cancer	4.52e-07	8.09e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PTGS2—prostate cancer	4.51e-07	8.09e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PTGS2—prostate cancer	4.47e-07	8.02e-06	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—AKT1—prostate cancer	4.41e-07	7.91e-06	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—AKT1—prostate cancer	4.29e-07	7.69e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PTEN—prostate cancer	4.28e-07	7.67e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CAV1—prostate cancer	4.27e-07	7.65e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PTEN—prostate cancer	4.18e-07	7.48e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—EP300—prostate cancer	4.08e-07	7.31e-06	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PIK3CA—prostate cancer	3.99e-07	7.16e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—EP300—prostate cancer	3.98e-07	7.14e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PTEN—prostate cancer	3.94e-07	7.05e-06	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PIK3CA—prostate cancer	3.91e-07	7.01e-06	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.9e-07	7e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PTEN—prostate cancer	3.9e-07	6.99e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.89e-07	6.96e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—EP300—prostate cancer	3.75e-07	6.73e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—EP300—prostate cancer	3.72e-07	6.67e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—INS—prostate cancer	3.68e-07	6.59e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CREBBP—prostate cancer	3.6e-07	6.46e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.42e-07	6.12e-06	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.38e-07	6.06e-06	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—AKT1—prostate cancer	3.26e-07	5.85e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—NOS3—prostate cancer	3.23e-07	5.78e-06	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—AKT1—prostate cancer	3.2e-07	5.73e-06	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—AKT1—prostate cancer	3.19e-07	5.72e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.02e-07	5.41e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.98e-07	5.34e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PTGS2—prostate cancer	2.95e-07	5.29e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PIK3CA—prostate cancer	2.95e-07	5.28e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.78e-07	4.98e-06	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—AKT1—prostate cancer	2.76e-07	4.95e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.75e-07	4.93e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PTEN—prostate cancer	2.57e-07	4.61e-06	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—AKT1—prostate cancer	2.47e-07	4.42e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—EP300—prostate cancer	2.45e-07	4.4e-06	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—AKT1—prostate cancer	2.41e-07	4.31e-06	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—AKT1—prostate cancer	2.27e-07	4.06e-06	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—AKT1—prostate cancer	2.25e-07	4.03e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.82e-07	3.25e-06	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—AKT1—prostate cancer	1.48e-07	2.66e-06	CbGpPWpGaD
